Medical Device Post Marketing Surveillance

Effective post market surveillance for medical devices post market surveillance pms is defined as a systematic process to derive necessary corrective and preventive actions capa from information on medical devices that are already placed on the market.

Medical device post marketing surveillance.

It has focused on collating and reporting adverse events such as device malfunctions or patient injuries in order to trigger product returns modifications exchanges and recalls as necessary. Post marketing surveillance guidelines is a collection of processes activities used to monitor the safety effectiveness of medical devices. Eu postmarket surveillance plans for medical devices pdf. Postmarketing surveillance pms also post market surveillance is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.

The medical device regulation mdr lays special emphasis on gathering clinical and safety related data after the approval ce certification process and market access. The fda adverse event reporting system faers is a computerized information database designed to support the fda s post marketing safety surveillance program for all approved drug and therapeutic. And post market phases. Post market surveillance pms is an important part of the regulatory framework for medical devices in europe.

Post market surveillance the key to better devices it s difficult to state that by removing the equivalence rule and replacing it with a more strict clinical trial requirement similar to the pharmaceutical industry we could have safer or more effective devices. Figure 3 risk managements documents required for the market placement of a medical device compared with a. The historical role of post market surveillance pms of medical devices has been reactive.